Top compounds associated with response to NSMCE2


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.061 0.2
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.044 0.2
mRNA YM201636 GDSC1000 pan-cancer AAC 0.042 0.2
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.066 0.2
mRNA lapatinib CTRPv2 pan-cancer AAC -0.048 0.2
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.04 0.2
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.047 0.2
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.2
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.047 0.2
Download CSV